Acelyrin Inc (NASDAQ:SLRN) price closed lower on Friday, November 17, dropping -0.57% below its previous close.
A look at the daily price movement shows that the last close reads $8.84, with intraday deals fluctuated between $8.42 and $9.01. Taking into account the 52-week price action we note that the stock hit a 52-week high of $29.88 and 52-week low of $7.68. The stock subtracted -10.40% on its value in the past month.
Acelyrin Inc, which has a market valuation of $854.74 million. Analysts tracking SLRN have forecast the quarterly EPS to shrink by -0.99 per share this quarter, while the same analysts predict the annual EPS to hit -$7.86 for the year 2023 and up to -$4.54 for 2024.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 5 analysts have assigned SLRN a recommendation rating as follows: 1 rate it as a Hold; 4 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Acelyrin Inc (SLRN) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that SLRN’s price is at present -5.20% off the SMA20 and -16.22% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 39.99, with weekly volatility standing at 6.55%. The indicator jumps to 6.96% when calculated based on the past 30 days. Acelyrin Inc (NASDAQ:SLRN)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.70. Considering analysts have assigned the stock a price target range of $15.00-$68.00 as the low and high respectively, we find the trailing 12-month average consensus price target to be $33.00. Based on this estimate, we see that current price is roughly -70.65% off the estimated low and -673.61% off the forecast high. Investors will no doubt be excited to see the share price fall to $24.50, which is the median consensus price, and at that level SLRN would be -178.73% from current price.
An analysis of the Acelyrin Inc (NASDAQ:SLRN) stock in terms of its daily trading volume indicates that the 3-month average is 1.31 million. However, this figure increases on the past 10-day timeline to an average of 1.11 million.
Current records show that the company has 92.70M in outstanding shares. The insiders’ percentage holdings are 35.24% of outstanding shares while the percentage share held by institutions stands at 68.89%. The stats also highlight that short interest as of Oct 30, 2023, stood at 8.23 million shares, which puts the short ratio at the time at 12.17. From this we can glean that short interest is 8.46% of company’s current outstanding shares. Notably, we see that shares short in October fall slightly given the previous month’s figure stood at 8.68 million. But the -62.60% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.